STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Albemarle Corporation (NYSE: ALB) discloses director Dean L. Seavers’ resignation

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Albemarle Corporation reported a change in its board leadership. On December 8, 2025, director Dean L. Seavers submitted his resignation from the company’s Board of Directors and from all committees on which he serves, with the resignation to become effective on December 12, 2025. The company stated that his decision to resign is not related to any disagreement regarding Albemarle’s operations, policies, or practices. This indicates a governance change without an identified dispute over the company’s direction or management approach.

Positive

  • None.

Negative

  • None.
false000091591300009159132025-12-082025-12-080000915913us-gaap:CommonStockMember2025-12-082025-12-080000915913us-gaap:SeriesAPreferredStockMember2025-12-082025-12-08

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_________________________________
FORM 8-K
_________________________________

CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): December 8, 2025

_________________________________
ALBEMARLE CORPORATION
(Exact name of registrant as specified in charter)
_________________________________
Virginia001-1265854-1692118
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
4250 Congress Street, Suite 900
Charlotte, North Carolina 28209
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (980) 299-5700
Not applicable
(Former name or former address, if changed since last report.)
_________________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a- 12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered
COMMON STOCK, $.01 Par ValueALBNew York Stock Exchange
DEPOSITARY SHARES, each representing a 1/20th interest in a share of 7.25% Series A Mandatory Convertible Preferred StockALB PR ANew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 




Item 5.02    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(b) On December 8, 2025, Dean L. Seavers tendered his resignation from the Board of Directors of Albemarle Corporation and all committees on which he serves, effective December 12, 2025. His resignation is not related to any disagreement regarding the organization’s operations, policies, or practices..





SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

ALBEMARLE CORPORATION
Date: December 12, 2025By:/s/ Ander C. Krupa
Ander C. Krupa
General Counsel and Corporate Secretary


FAQ

What board change did Albemarle Corporation (ALB) announce?

Albemarle Corporation announced that Dean L. Seavers resigned from its Board of Directors and all related committees, effective December 12, 2025.

Did Albemarle (ALB) report any disagreement linked to Dean L. Seavers’ resignation?

No. The company stated that his resignation is not related to any disagreement regarding Albemarle’s operations, policies, or practices.

When did Dean L. Seavers submit his resignation from Albemarle’s board?

Dean L. Seavers tendered his resignation on December 8, 2025, with an effective date of December 12, 2025.

Which committees did Dean L. Seavers leave at Albemarle Corporation?

He resigned from all committees of the Albemarle Corporation Board of Directors on which he served.

Who signed the Albemarle 8-K reporting the director resignation?

The report was signed on behalf of Albemarle Corporation by Ander C. Krupa, General Counsel and Corporate Secretary.

Does this Albemarle 8-K include any financial results or major transactions?

No. The disclosure focuses on the resignation of a director and does not provide earnings data or major transaction details.
Albemarle Corp

NYSE:ALB

ALB Rankings

ALB Latest News

ALB Latest SEC Filings

ALB Stock Data

15.84B
117.22M
0.41%
98.74%
10.83%
Specialty Chemicals
Plastic Materials, Synth Resins & Nonvulcan Elastomers
Link
United States
CHARLOTTE